These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7287186)

  • 21. Synthesis and biological activities of N-acetyl-1-thiomuramoyl-L-alanyl-D-isoglutamine and some of its lipophilic derivatives.
    Hasegawa A; Hioki Y; Kiso M; Okumura H; Azuma I
    Carbohydr Res; 1983 Nov; 123(2):183-99. PubMed ID: 6661739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis of N-acetyl-6-amino- and -6-(acylamino)-6-deoxymuramoyl dipeptides, and their immunoadjuvant activities.
    Hasegawa A; Okumura H; Kiso M; Azuma I; Yamamura Y
    Carbohydr Res; 1980 Feb; 79(1):C20-3. PubMed ID: 7357567
    [No Abstract]   [Full Text] [Related]  

  • 23. Synthesis of (N-acetyl-1-O-acylmuramoyl)-L-alanyl-D-isoglutamines, and their immunoadjuvant activities.
    Hasegawa A; Hioki Y; Kiso M; Azuma I
    Carbohydr Res; 1983 Nov; 123(1):63-71. PubMed ID: 6667479
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and immunoadjuvant activity of N-[2-O-(2-acetamido- 1,2,3,5-tetradeoxy-1,5-imino-D-glucitol-3-yl)-D-lactoyl]- L-alanyl-D-isoglutamine.
    Ishida H; Kitagawa M; Kiso M; Hasegawa A; Azuma I
    Carbohydr Res; 1990 Dec; 208():267-72. PubMed ID: 2085813
    [No Abstract]   [Full Text] [Related]  

  • 25. Immunoadjuvant activities of synthetic N-acetyl-muramyl-peptides or -amino acids.
    Kotani S; Watanabe Y; Kinoshita F; Shimono T; Morisaki I
    Biken J; 1975 Jun; 18(2):105-11. PubMed ID: 1180867
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kinetics of the humoral and cellular immune response of guinea pigs after injection of the synthetic adjuvant N-acetylmuramyl L-alanyl-D-isoglutamine: comparison with Freund complete adjuvant.
    Souvannavong V; Adam A; Lederer E
    Infect Immun; 1978 Mar; 19(3):966-71. PubMed ID: 346491
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunoadjuvant activity of synthetic N-acetyl muramyl dipeptide.
    Masek K; Zaoral M; Jezek J; Straka R
    Experientia; 1978 Oct; 34(10):1363-4. PubMed ID: 738426
    [No Abstract]   [Full Text] [Related]  

  • 28. Synthesis and biological activity of some lipophilic derivatives of 1-thio-muramoyl-L-alanyl-D-isoglutamine.
    Hasegawa A; Seki E; Hioki Y; Kiso M; Azuma I
    Carbohydr Res; 1984 Aug; 131(1):61-9. PubMed ID: 6488202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adjuvant polyarthritis. V. Induction by N-acetylmuramyl-L-alanyl-D-isoglutamine, the smallest peptide subunit of bacterial peptidoglycan.
    Chang YH; Pearson CM; Chedid L
    J Exp Med; 1981 Apr; 153(4):1021-6. PubMed ID: 6972989
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-specific MIF-like activity induced by the synthetic immunoadjuvant: N-acetyl muramyl-L-alanyl-D-isoglutamine (MDP).
    Adam A; Souvannavong V; Lederer E
    Biochem Biophys Res Commun; 1978 Nov; 85(2):684-90. PubMed ID: 367370
    [No Abstract]   [Full Text] [Related]  

  • 31. Efficient genetically controlled formation of antibody to a synthetic antigen [poly(LTyr, LGlu)-poly(DLAla)- -poly(LLys)] covalently bound to a synthetic adjuvant (N-acetylmuramyl-L-alanyl-D-isoglutamine).
    Mozes E; Sela M; Chedid L
    Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4933-7. PubMed ID: 6776530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of a synthetic adjuvant (MDP) on qualitative and quantitative changes of serum globulins.
    Leclerc C; Audibert F; Chedid L
    Immunology; 1978 Dec; 35(6):963-70. PubMed ID: 738768
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Adjuvant activity and adjuvant arthritis].
    Tanaka A
    Kekkaku; 1980 Oct; 55(10):465-7. PubMed ID: 7230587
    [No Abstract]   [Full Text] [Related]  

  • 34. Synthesis, mass spectral characterization and immunoadjuvant activity of some novel lipophilic derivatives of muramyl dipeptides.
    Jain RK; Gupta CM; Saxena RK; Saxena RP; Saxena KC; Shukla R; Anand N; Costello CE
    Chem Phys Lipids; 1986; 41(3-4):237-64. PubMed ID: 3815623
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Augmentation of the proliferative response of thymocytes to phytohemagglutinin by the muramyl dipeptide1.
    Iribe H; Koga T
    Cell Immunol; 1984 Oct; 88(1):9-15. PubMed ID: 6332683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adjuvant activity of 6-O-mycoloyl-N-acetylmuramuyl-L-alanyl-D-isoglutamine.
    Yamamura Y; Azuma I; Sugimura K; Yamawaki M; Uemiya M
    Gan; 1976 Dec; 67(6):867-77. PubMed ID: 828599
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of natural or synthetic microbial adjuvants on induction of autoimmune thyroiditis.
    Kong YC; Audibert F; Giraldo AA; Rose NR; Chedid L
    Infect Immun; 1985 Jul; 49(1):40-5. PubMed ID: 3839208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute and chronic polyarthritis induced by an aqueous form of 6-O-acyl and N-acyl derivatives of N-acetylmuramyl-L-alanyl-D-isoglutamine in euthymic rats and athymic nude rats.
    Kohashi O; Kohashi Y; Shigematsu N; Ozawa A; Kotani S
    Lab Invest; 1986 Sep; 55(3):337-46. PubMed ID: 3489128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modification of delayed-type hypersensitivity reactions by muramyldipeptide in guinea pigs.
    Nagao S; Kawabata Y; Kitano M; Suzuki K; Nishikawa T; Takada H
    FEMS Immunol Med Microbiol; 1995 Jun; 11(3):231-45. PubMed ID: 7581275
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adjuvant activity of 6-O-acyl-muramyldipeptides to enhance primary cellular and humoral immune responses in guinea pigs: adaptability to various vehicles and pyrogenicity.
    Tsujimoto M; Kotani S; Kinoshita F; Kanoh S; Shiba T; Kusumoto S
    Infect Immun; 1986 Sep; 53(3):511-6. PubMed ID: 3744548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.